ABUS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arbutus Biopharma Corp

Watchlist Manager

Watchlist

Price: 4.23 USD 0.71%

Market Cap: $835.6m

	Arbutus Biopharma Corp NASDAQ:ABUS	CA
	JCDecaux SE PAR:DEC	FR
	Yunfeng Financial Group Ltd F:MNA1	HK
E	Entravision Communications Corp F:EV9	US
E	EFC (I) Ltd NSE:EFCIL	IN
P	PDF Solutions Inc XMUN:PD9	US
H	Hongkong and Shanghai Hotels Ltd OTC:HKSHF	HK
S	Sahamitr Pressure Container PCL SET:SMPC	TH
D	Dubber Corp Ltd OTC:DUBRF	AU

Profitability Summary

Arbutus Biopharma Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

82%

Negative 3Y Average Operating Margin

-527%

Operating Margin is Increasing

-359% > 82%

Exceptional Net Margin

84%

Negative 3Y Average Net Margin

-538%

Net Margin is Increasing

-339% > 84%

Negative Free Cash Flow Margin

-14%

Negative 3Y Average Free Cash Flow Margin

-534%

Free Cash Flow Margin is Increasing

-390% > -14%

Exceptional ROE

90%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-367%

ROIC is Increasing

-177% > 162%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.